Free Daily Headlines :

  • COVID-19
  • Vaccine Info
  • Money
  • Politics
  • Education
  • Health
  • Justice
  • More
    • Environment
    • Economic Development
    • Gaming
    • Investigations
    • Social Services
    • TRANSPORTATION
  • Opinion
    • CT Viewpoints
    • CT Artpoints
DONATE
Reflecting Connecticut’s Reality.
    COVID-19
    Vaccine Info
    Money
    Politics
    Education
    Health
    Justice
    More
    Environment
    Economic Development
    Gaming
    Investigations
    Social Services
    TRANSPORTATION
    Opinion
    CT Viewpoints
    CT Artpoints

LET�S GET SOCIAL

Show your love for great stories and out standing journalism
CT VIEWPOINTS -- opinions from around Connecticut

Pass the Prescription Drug Pricing Reduction Act

Big Pharma has been gouging the public long enough

  • CT Viewpoints
  • by Nora Duncan
  • August 7, 2019
  • View as "Clean Read" "Exit Clean Read"

For decades, Big Pharma has raised drug prices with impunity. Here in Connecticut, the average annual cost of brand name prescription drug treatment increased 58 percent between 2012 and 2017, while the annual income for residents of the Constitution State increased only 12 percent. Prescription drugs do not work if patients cannot afford them.

That is why the U.S. Senate needs to pass the Prescription Drug Pricing Reduction Act when they return from August recess. We urge Sens. Richard Blumenthal and Chris Murphy to back this vital legislation, which passed the Senate Finance Committee in July with strong bipartisan support, and to support allowing Medicare to negotiate with drug companies for lower prices.

For too long, drug companies have been price gouging seniors and hardworking Americans. Consider insulin, which people with diabetes rely on. Its price nearly tripled from 2002 to 2013. But it isn’t a breakthrough drug: insulin was invented nearly a century ago, yet modern formulations remain under patent, thanks to drug makers manipulating the system. Some patients trek to Canada to get this lifesaving treatment at a price they can afford, while others risk their lives by rationing or skipping doses.

Even those of us who don’t need insulin or other prescription drugs are affected by skyrocketing drug prices. We pay not only at the pharmacy counter, but through higher insurance premiums, and through the higher taxes we need to pay to fund programs like Medicare and Medicaid. Older Americans are hit especially hard. Medicare Part D enrollees take an average of four to tive prescriptions per month, and their average annual income is around $26,000. One in three Americans has not taken a medication as prescribed because of the cost.

The root cause of the problem is clear: the high prices of prescription drugs set by pharmaceutical companies when they first come on the market, which then increase faster than inflation year after year.

In March, AARP launched a nationwide campaign called “Stop Rx Greed” to rein in drug prices. The bill under consideration in the Senate would cap out-of-pocket drug costs for seniors and crack down on drug makers whose price hikes outpace inflation. The nation clearly needs this reform: the average prescription drug price increase in the first six months of 2019 was 10.5 percent — five times the rate of inflation. We in Connecticut, like all Americans, already pay among the highest drug prices in the world.

Meanwhile, Big Pharma is fighting for the status quo – and blocking needed improvements to the system that could bring relief to seniors, families, and small businesses. Drug giants Merck, Amgen and Eli Lilly actually sued the Trump administration so they could keep the list prices of their drugs secret from the public. The industry is spending record sums to hire Washington lobbyists, and they are running ads claiming that more affordable drugs will actually harm consumers.

But the tide is turning. The National Academy for State Health Policy reports that, so far this year, 29 states have passed 47 new laws aimed at lowering prices for prescription medications. Several pieces of good legislation aimed at controlling or reducing prescription medication prices failed to pass in Connecticut this year. While AARP Connecticut will continue to fight for necessary changes on the state level, drug costs are also a national issue, and federal action is equally essential.

In D.C., there is rare bipartisan agreement that something must be done. President Trump addressed the issue in his State of the Union, saying: “It is unacceptable that Americans pay vastly more than people in other countries for the exact same drugs, often made in the exact same place. This is wrong, unfair, and together we can stop it.” Connecticut’s congressional delegation is in the position to lead on this issue and make a difference for all of us.

We urge the Senate to pass the Prescription Drug Pricing Reduction Act in the fall, when the House is expected to act on its own drug-pricing bill.

While there is reason to be hopeful that drug prices will come down, hope is not enough. Too much is at stake. None of us should ever be forced to choose between putting food on the table or buying a lifesaving medication. This legislation should be at the top of the agenda when the Senate returns to Washington.

Nora Duncan is State Director of the AARP in Connecticut.

CTViewpoints welcomes rebuttal or opposing views to this and all its commentaries. Read our guidelines and submit your commentary here.

Sign up for CT Mirror's free daily news summary.

ABOUT THE AUTHOR

SEE WHAT READERS SAID

RELATED STORIES
Fitness is part of Connecticut’s COVID solution
by David Humphrey

Based on what we now know about infection rates and transmission, it is more apparent than ever before that gyms, fitness centers, and the physical and mental health benefits of exercise are essential to help our state get through the months ahead.

Connecticut can’t afford state government-run health insurance
by Mike Licamele

As much as I support strengthening and improving healthcare, I do not believe SB 842 is the way to do that. Instead of trying to force Connecticut residents into a new, government-controlled healthcare system, lawmakers should focus on improving our existing one by building on what’s working and continuing to address lowering costs, not raising taxes

Disabled, marginalized, stalled and walled
by Doris Maldonado

As a bilingual health information specialist for PATH P2P Family Voices CT and National Family Voices Cultural Responsiveness Telehealth Team, I offer more than professional expertise as well as despair for the marginalized within marginalized communities. I am a Latina with disabilities, adoptive mother of 17-year-old twins with special needs and a thriving toddler.

The marijuana legalization debate must be based on facts
by Will Jones III

In response to my earlier piece on why Connecticut lawmakers should reject marijuana commercialization,  Brendan Ruberry wrote a rebuttal that, on its face seems scathing, but to be clear, the attempted rebuttal falls flat and well off the mark.

Equity for women and girls essential to rebuild Connecticut’s economy
by Jennifer Steadman and Michelle Riordan-Nold

As Connecticut’s economy seeks to recover and rebuild, our success as a state will depend on how we respond to the disproportionate adverse impact of the coronavirus pandemic on women and girls, particularly women and girls of color.

Support Our Work

Show your love for great stories and outstanding journalism.

$
Select One
  • Monthly
  • Yearly
  • Once
Artpoint painter
CT ViewpointsCT Artpoints
Opinion Fitness is part of Connecticut’s COVID solution
by David Humphrey

Based on what we now know about infection rates and transmission, it is more apparent than ever before that gyms, fitness centers, and the physical and mental health benefits of exercise are essential to help our state get through the months ahead.

Opinion Connecticut can’t afford state government-run health insurance
by Mike Licamele

As much as I support strengthening and improving healthcare, I do not believe SB 842 is the way to do that. Instead of trying to force Connecticut residents into a new, government-controlled healthcare system, lawmakers should focus on improving our existing one by building on what’s working and continuing to address lowering costs, not raising taxes

Opinion Disabled, marginalized, stalled and walled
by Doris Maldonado

As a bilingual health information specialist for PATH P2P Family Voices CT and National Family Voices Cultural Responsiveness Telehealth Team, I offer more than professional expertise as well as despair for the marginalized within marginalized communities. I am a Latina with disabilities, adoptive mother of 17-year-old twins with special needs and a thriving toddler.

Opinion The marijuana legalization debate must be based on facts
by Will Jones III

In response to my earlier piece on why Connecticut lawmakers should reject marijuana commercialization,  Brendan Ruberry wrote a rebuttal that, on its face seems scathing, but to be clear, the attempted rebuttal falls flat and well off the mark.

Artwork Grand guidance
by Anne:Gogh

In a world of systemic oppression aimed towards those of darker skintones – representation matters. We are more than our equity elusive environments, more than numbers in a prison and much more than victims of societal dispositions. This piece depicts a melanated young man draped in a cape ascending high above multiple forms of oppression. […]

Artwork Shea
by Anthony Valentine

Shea is a story about race and social inequalities that plague America. It is a narrative that prompts the question, “Do you know what it’s like to wake up in new skin?”

Artwork The Declaration of Human Rights
by Andres Chaparro

Through my artwork I strive to create an example of ideas that reflect my desire to raise social consciousness, and cultural awareness. Jazz music is the catalyst to all my work, and plays a major influence in each piece of work.”

Artwork ‘A thing of beauty. Destroy it forever’
by Richard DiCarlo | Derby

During times like these it’s often fun to revisit something familiar and approach things with a different slant. I have been taking some Pop culture and Art masterpieces and applying the vintage 1960’s and 70’s classic figures (Fisher Price, little people) to the make an amusing pieces. Here is my homage to Fisher -Price, Yellow […]

Twitter Feed
A Twitter List by CTMirror

Engage

  • Reflections Tickets & Sponsorships
  • Events
  • Donate
  • Newsletter Sign-Up
  • Submit to Viewpoints
  • Submit to ArtPoints
  • Economic Indicator Dashboard
  • Speaking Engagements
  • Commenting Guidelines
  • Legal Notices
  • Contact Us

About

  • About CT Mirror
  • Announcements
  • Board
  • Staff
  • Sponsors and Funders
  • Donors
  • Friends of CT Mirror
  • History
  • Financial
  • Policies
  • Strategic Plan

Opportunity

  • Advertising and Sponsorship
  • Speaking Engagements
  • Use of Photography
  • Work for Us

Go Deeper

  • Steady Habits Podcast
  • Economic Indicator Dashboard
  • Five Things

The Connecticut News Project, Inc. 1049 Asylum Avenue, Hartford, CT 06105. Phone: 860-218-6380

© Copyright 2021, The Connecticut News Project. All Rights Reserved. Website by Web Publisher PRO